Transparency Commission publishes its opinion for Kymriah

14 December 2018 - Opinion published following an examination of written submissions on 12 December 2018. ...

Read more →

Transparency Commission publishes its opinion for Yescarta

7 December 2018 - Opinion published following an examination of written submissions on 5 December 2018. ...

Read more →

Transparency Commission publishes opinion for Keytruda

20 June 2017 - The opinion relates to the use of pembrolizumab for the first-line use in patients with non-small-cell ...

Read more →

Transparency Commission revises ASMR for Imbruvica

1 June 2017 - The Transparency Commission has published its revised opinion on the ASMR for ibrutinib for patients with ...

Read more →

Transparency Commission publishes its review of Keytruda's SMR & ASMR

22 May 2017 - The Transparency Commission has reviewed its SMR & ASMR ratings of pembrolizumab for malignant melanoma. ...

Read more →

TC publishes opinion on Pfizer's Ibrance

11 May 2017 - The Commission considers that the medical service rendered by palbociclib when used in combination with letrozole ...

Read more →

HAS publishes Transparency Commission opinion for Keytruda

12 April 2017 - The opinion relates the use of pembrolizumab by patients with non-small-cell lung cancer. ...

Read more →